(2S)-2-(2-PROPEN-1-YL) PYRROLIDINE HYDROCHLORIDE, 95%, 500mg

1,5-Dihydro-1,5-naphthyridine-2,6-dione, 98%, 50mg

Plan PLi 4x/0.10 infinity corrected IOS objective. Working distance 21.0 mm

tert-butyl (S)-3-(4-Amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate, 97%, 1g

4-Chloropyridine-2,6-dicarboxylic acid, 95.0%, 500g

(2,2-Dimethyl-1-pyrrolidin-1-ylmethyl-propyl)-methyl-amine, 98.0%, 500mg

N-(2,3-dimethoxybenzyl)-2-propanamine hydrochloride, 95.0%, 1g

(4-oxo-1(4H)-quinolinyl)acetic acid, 95.0%, 1g

(11bR)-4-Hydroxy-2,6-bis(perfluorophenyl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 250mg

3'-chloro-2-thiomorpholinomethyl benzophenone, 97.0%, 1g

3-(Pyridin-2-yl)propan-1-ol, 99.0%, 5g

Zinc granules, min. 99.99% pa, grain size, 5-15 mm, 1 kg, plastic packaging.

3,3-DIMETHYL-1-(METHYLAMINO)BUTAN-2-ONE, 95.0%, 250mg